Insomnia of older people and use of benzodiazepines in Taiwan  by Chu, Ching-Liang & Chen, Liang-Kung
at SciVerse ScienceDirect
Journal of Clinical Gerontology & Geriatrics 4 (2013) 67–68Contents lists availableJournal of Clinical Gerontology & Geriatrics
journal homepage: www.e- jcgg.comEditorial
Insomnia of older people and use of benzodiazepines in TaiwanInsomnia is a patient-reported problem, which is characterized
by difﬁculty of falling asleep, maintaining sleep, or waking up too
early. Although polysomnography or actigraphy can be an objective
sleep measure, insomnia is not deﬁned by a speciﬁc amount of
sleep. Ultimately, individuals with insomnia cannot be distin-
guished reliably from good sleepers by self-reported sleep symp-
toms, such as sleep latency (time to fall asleep) or wakefulness
after sleep onset lasting for longer than 30 minutes.1 Insomnia dis-
orders have been categorized as primary and secondary insomnia,
depending on whether the sleep problem resulted from certain
medical or mental disorders or from medication/substance use.
Primary insomnia is also described as psychophysiological
insomnia. Pathophysiological studies have suggested that patients
with primary insomnia are hyperaroused during sleep and wake-
fulness.2 Evidence supporting the hyperarousal state in insomnia
includes elevated whole-body metabolic rate during sleep and
wakefulness, elevated cortisol and adrenocorticotropic hormones
during the early sleep period,3 and a smaller difference in regional
brain metabolism between waking and sleep.4
The changes in sleep patterns of older people include reduced
total sleep time, more daytime napping, and decreased sleep efﬁ-
ciency. Changes occur in their sleep architecture as well, such as
less slow wave and rapid eye movement sleep, more stage I and
II sleep, shorter rapid eye movement latency, and longer sleep la-
tency. These changes in sleep patternsmay be reported as insomnia
among older people. The prevalence of insomnia in older people
has been reported to range from 30% to 60%.5 The differences in
epidemiology may have resulted from different study populations
enrolled in each study, different deﬁnitions of insomnia, and so
on. Eventually, the prevalence of insomnia symptoms and sleep
dissatisfaction do not increase signiﬁcantly with age,6 and healthy
older people sleep as well as younger populations.
In this issue of the Journal of Clinical Gerontology and Geriatrics,
Dr Tsou reports an epidemiological study to determine the preva-
lence and risk factors of insomnia among community-dwelling
elderly in northern Taiwan.7 Although some similar studies have
already been published,8,9 important phenomena reported in
Tsou et al’s study deserve attentions. First, advanced age was not
associated with the prevalence of insomnia among community-
dwelling healthy elderly individuals. This was compatible with
the results of a previous review article5 and strengthened the
observation. Second, in this study, risk factors for insomnia
included physical symptoms, receipt of medication for chronic dis-
eases, mental health status, living status, and perceived level of
well-being. Identiﬁcation of these risk factors deserves more2210-8335 Copyright  2013 Asia Paci, ﬁc League of Clinical Gerontology & Geriatrics P.
http://dx.doi.org/10.1016/j.jcgg.2013.04.005intervention studies to improve quality of sleep for patients with
insomnia, thus improving their quality of life. The treatment strate-
gies for insomnia included nonpharmacological and pharmacolog-
ical approaches. The main nonpharmacological treatments were
stimulus control therapy, sleep restriction therapy, relaxation ther-
apy, cognitive therapy, and sleep hygiene education. In the elderly,
behavioral therapies seemed to be as effective as pharmacological
therapies,10 and they may have had more enduring effects after
cessation.11,12 The major problem associated with current nonphar-
macological therapies was not their efﬁcacy, but the lack of aware-
ness among clinicians and of sufﬁciently trained and skilled service
providers.
In general, pharmacological therapywas initiated if nonpharma-
cological strategies did not show satisfactory improvement. The
most commonly used pharmaceutical agents for insomnia were
benzodiazepine or nonbenzodiazepine hypnotics. Huang and
Lai13 explored prescription patterns and determinants of sleep-
related medications prescribed to elderly outpatients with
insomnia in Taiwan through the claim data of Taiwan’s National
Health Insurance, which showed that 11.14% of older people had
been diagnosed with insomnia in 2001, and the most commonly
prescribed sleep medications were lorazepam and zolpidem. How-
ever, the use of benzodiazepines among older people was not
restricted to the treatment of insomnia, but encompassed many
other psychiatric conditions as well. Another study investigated
the prevalence and associative factors of benzodiazepine use
among older people in outpatient settings,14 which showed that
1-year prevalence of benzodiazepine use was approximately 43%.
Among them, 22% of older people continued the use of benzodiaz-
epine for more than 6 months in 2002 and for 14% the prescribed
dose was higher than the deﬁned daily dose. Although women
weremore likely to receive benzodiazepines, bothmen andwomen
demonstrated similar benzodiazepine use patterns. Mental disor-
ders and previous exposures to higher cumulative dosages of ben-
zodiazepines were associated with a higher chance of receiving
benzodiazepines for a longer period of time and at a higher dosage.
Based on the results of the aforementioned studies, benzodiazepine
use among elderly people in Taiwan did not completely comply
with treatment recommendations,15 but the associative factors for
benzodiazepine use were similar to those reported in a previous
study from Western countries.16 Use of benzodiazepines in older
people increases the risk of falls and related injuries signiﬁcantly,
a ﬁnding that deserves extensive attention. Reducing the use of
benzodiazepines in Taiwanwas dependent on various factors. How-
ever, to screen the risk factors for insomnia and to prioritize the useublished by Elsevier Taiwan LLC. Open access under CC BY-NC-ND license.
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benzodiazepines for older people.
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